IMPROVING LIVES WITH PRECISION DIAGNOSTICS

WIPO WIPO 2019

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die Internationale Marke IMPROVING LIVES WITH PRECISION DIAGNOSTICS wurde als Wortmarke am 19.03.2019 bei der Weltorganisation für geistiges Eigentum angemeldet.

Markendetails Letztes Update: 20. Oktober 2022

Markenform Wortmarke
Aktenzeichen 1464865
Länder Schweiz China Europäische Gemeinschaft Japan Südkorea
Basismarke US Nr. 88153684, 12. Oktober 2018
Anmeldedatum 19. März 2019
Ablaufdatum 19. März 2029

Markeninhaber

10222 Barnes Canyon Road,
Building 1
US

Markenvertreter

Level 43, Bourke Place, 600 Bourke Street AU

Waren und Dienstleistungen

01 Reagents for scientific and research use, namely, buffer solutions, enzymes, molecular probes, DNA and RNA polymerases, nucleic acids, nucleic acid derivatives, primers for use in polymerase chain reaction, DNA templates, RNA templates, dyes and biotechnology reagents and solvents for sample preparation, purification, lysis, modification and manipulation of cells; diagnostic reagent kits for scientific and research use comprised of buffer solutions, enzymes, molecular probes, DNA and RNA polymerases, nucleic acids, nucleic acid derivatives, primers for use in polymerase chain reaction, DNA templates, RNA templates, dyes and biotechnology reagents and solvents for sample preparation, purification, lysis, modification and manipulation of cells; diagnostic reagent kits for scientific and research use comprised of chemical and biological reagents for non-medical purposes; diagnostic reagents for scientific and research use; diagnostic assays for research, clinical research, and laboratory research use
05 Assays for the treatment or diagnosis of disease; medical diagnostic reagents, namely, buffer solutions, enzymes, molecular probes, DNA and RNA polymerases, nucleic acids, nucleic acid derivatives, primers for use in polymerase chain reaction, DNA templates, RNA templates, dyes and biotechnology reagents and solvents for sample preparation, purification, lysis, modification and manipulation of cells; medical diagnostic kits comprised of buffer solutions, enzymes, molecular probes, DNA and RNA polymerases, nucleic acids, nucleic acid derivatives, primers for use in polymerase chain reaction, DNA templates, RNA templates, dyes and biotechnology reagents and solvents for sample preparation, purification, lysis, modification and manipulation of cells; medical diagnostic reagent kits comprised of chemical and biological reagents for the treatment, monitoring and diagnosis of disease; medical diagnostic reagent kits comprised of medical reagents for clinical or medical use; medical diagnostic assays for the treatment and diagnosis of disease; medical diagnostic assays for testing of bodily fluids
42 DNA analysis services for scientific research purposes, namely, DNA sequencing, bioinformatics analysis, and interpretation of biological DNA data generated from reagents and assays; providing medical testing and consultation services for both clinical research and research applications
44 DNA screening for medical purposes, namely, DNA sequencing, bioinformatics analysis, and interpretation of biological DNA data generated from reagents and assays; providing information services regarding the diagnosis, monitoring and options in the treatment of leukemia; providing medical testing and consultation services for clinical applications
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

Markenhistorie

Datum Belegnummer Bereich Eintrag
17. Dezember 2020 2020/51 Gaz JP RAW: Rule 18ter(2)(i) GP following a provisional refusal
14. September 2020 2020/38 Gaz CH Ablehnung
26. August 2020 2020/39 Gaz RAW: Limitation
07. Juli 2020 2020/28 Gaz KR Ablehnung
25. Juni 2020 2020/26 Gaz JP Ablehnung
31. März 2020 2020/15 Gaz CH Ablehnung
03. März 2020 2020/11 Gaz EM Ablehnung
03. Februar 2020 2020/6 Gaz KR Ablehnung
24. Juni 2019 2019/26 Gaz CN Ablehnung
13. Juni 2019 2019/25 Gaz EM Ablehnung
19. März 2019 2019/16 Gaz US Eintragung

ID: 141464865